ID   TYK2_HUMAN              Reviewed;        1187 AA.
AC   P29597; Q6QB10; Q96CH0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 3.
DT   02-NOV-2010, entry version 118.
DE   RecName: Full=Non-receptor tyrosine-protein kinase TYK2;
DE            EC=2.7.10.2;
GN   Name=TYK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PHE-362 AND SER-684.
RX   MEDLINE=91016433; PubMed=2216457;
RA   Firmbach-Kraft I., Byers M., Shows T., Dalla-Favera R.,
RA   Krolewski J.J.;
RT   "TYK2, prototype of a novel class of non-receptor tyrosine kinase
RT   genes.";
RL   Oncogene 5:1329-1336(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-4; HIS-197;
RP   PHE-362; SER-363 AND SER-684.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 289-1187.
RX   PubMed=1386289; DOI=10.1016/0092-8674(92)90105-L;
RA   Velazquez L., Fellous M., Stark G.R., Pellegrini S.;
RT   "A protein tyrosine kinase in the interferon alpha/beta signaling
RT   pathway.";
RL   Cell 70:313-322(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1007-1162, AND TISSUE SPECIFICITY.
RX   MEDLINE=90191712; PubMed=2156206;
RA   Krolewski J.J., Lee R., Eddy R., Shows T.B., Dalla-Favera R.;
RT   "Identification and chromosomal mapping of new human tyrosine kinase
RT   genes.";
RL   Oncogene 5:277-282(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1025-1082.
RX   MEDLINE=91062389; PubMed=2247464; DOI=10.1073/pnas.87.22.8913;
RA   Partanen J., Maekelae T.P., Alitalo R., Lehvaeslaiho H., Alitalo K.;
RT   "Putative tyrosine kinases expressed in K-562 human leukemia cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8913-8917(1990).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF IFNAR1.
RX   MEDLINE=95059042; PubMed=7526154;
RA   Colamonici O., Yan H., Domanski P., Handa R., Smalley D.,
RA   Mullersman J., Witte M., Krishnan K., Krolewski J.;
RT   "Direct binding to and tyrosine phosphorylation of the alpha subunit
RT   of the type I interferon receptor by p135tyk2 tyrosine kinase.";
RL   Mol. Cell. Biol. 14:8133-8142(1994).
RN   [8]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=15277531; DOI=10.1074/jbc.M401915200;
RA   Steindler C., Li Z., Algarte M., Alcover A., Libri V., Ragimbeau J.,
RA   Pellegrini S.;
RT   "Jamip1 (marlin-1) defines a family of proteins interacting with Janus
RT   kinases and microtubules.";
RL   J. Biol. Chem. 279:43168-43177(2004).
RN   [9]
RP   INVOLVEMENT IN TYK2 DEFICIENCY.
RX   PubMed=17088085; DOI=10.1016/j.immuni.2006.09.009;
RA   Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K.,
RA   Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., Kaneko H.,
RA   Kondo N., Tsuge I., Yachie A., Sakiyama Y., Iwata T., Bessho F.,
RA   Ohishi T., Joh K., Imai K., Kogawa K., Shinohara M., Fujieda M.,
RA   Wakiguchi H., Pasic S., Abinun M., Ochs H.D., Renner E.D., Jansson A.,
RA   Belohradsky B.H., Metin A., Shimizu N., Mizutani S., Miyawaki T.,
RA   Nonoyama S., Karasuyama H.;
RT   "Human tyrosine kinase 2 deficiency reveals its requisite roles in
RT   multiple cytokine signals involved in innate and acquired immunity.";
RL   Immunity 25:745-755(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; SER-499 AND
RP   SER-884, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; SER-499 AND
RP   SER-884, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-362; SER-363; MET-386; SER-684;
RP   TRP-703; ARG-732; VAL-928; ALA-1104 AND GLY-1163.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably involved in intracellular signal transduction
CC       by being involved in the initiation of type I IFN signaling.
CC       Phosphorylates the interferon-alpha/beta receptor alpha chain.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with JAKMIP1.
CC   -!- TISSUE SPECIFICITY: Observed in all cell lines analyzed. Expressed
CC       in a variety of lymphoid and non-lymphoid cell lines.
CC   -!- DOMAIN: The FERM domain mediates interaction with JAKMIP1.
CC   -!- DISEASE: Defects in TYK2 are the cause of protein-tyrosine kinase
CC       2 deficiency (TYK2 deficiency) [MIM:611521]; also known as
CC       autosomal recessive hyper-IgE syndrome (HIES) with atypical
CC       mycobacteriosis. TYK2 deficiency consists of a primary
CC       immunodeficiency characterized by recurrent skin abscesses,
CC       pneumonia, and highly elevated serum IgE.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily.
CC   -!- SIMILARITY: Contains 1 FERM domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- WEB RESOURCE: Name=TYK2base; Note=TYK2 mutation db;
CC       URL="http://bioinf.uta.fi/TYK2base/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/tyk2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54637; CAA38449.1; -; mRNA.
DR   EMBL; AY549314; AAS37680.1; -; Genomic_DNA.
DR   EMBL; BC014243; AAH14243.1; -; mRNA.
DR   IPI; IPI00022353; -.
DR   PIR; S12127; TVHUY2.
DR   RefSeq; NP_003322.3; -.
DR   UniGene; Hs.75516; -.
DR   PDB; 3LXN; X-ray; 2.50 A; A=888-1182.
DR   PDB; 3LXP; X-ray; 1.65 A; A=888-1182.
DR   PDBsum; 3LXN; -.
DR   PDBsum; 3LXP; -.
DR   ProteinModelPortal; P29597; -.
DR   SMR; P29597; 44-277, 451-867, 889-1172.
DR   DIP; DIP-1062N; -.
DR   IntAct; P29597; 7.
DR   MINT; MINT-107878; -.
DR   STRING; P29597; -.
DR   PhosphoSite; P29597; -.
DR   PRIDE; P29597; -.
DR   Ensembl; ENST00000264818; ENSP00000264818; ENSG00000105397.
DR   GeneID; 7297; -.
DR   KEGG; hsa:7297; -.
DR   UCSC; uc002moc.2; human.
DR   CTD; 7297; -.
DR   GeneCards; GC19M010461; -.
DR   H-InvDB; HIX0202831; -.
DR   HGNC; HGNC:12440; TYK2.
DR   HPA; HPA005157; -.
DR   MIM; 176941; gene.
DR   MIM; 611521; phenotype.
DR   Orphanet; 169446; Autosomal recessive hyper IgE syndrome.
DR   PharmGKB; PA37094; -.
DR   eggNOG; prNOG11791; -.
DR   HOGENOM; HBG445257; -.
DR   HOVERGEN; HBG006195; -.
DR   InParanoid; P29597; -.
DR   OMA; SFKDCIP; -.
DR   OrthoDB; EOG9ZPHFM; -.
DR   PhylomeDB; P29597; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; il23pathway; IL23-mediated signaling events.
DR   Pathway_Interaction_DB; il27pathway; IL27-mediated signaling events.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Pathway_Interaction_DB; ptp1bpathway; Signaling events mediated by PTP1B.
DR   NextBio; 28539; -.
DR   ArrayExpress; P29597; -.
DR   Bgee; P29597; -.
DR   CleanEx; HS_TYK2; -.
DR   Genevestigator; P29597; -.
DR   GermOnline; ENSG00000105397; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005131; F:growth hormone receptor binding; IPI:BHF-UCL.
DR   GO; GO:0004718; F:Janus kinase activity; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; TAS:ProtInc.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IEA:InterPro.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:InterPro.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR009131; Tyr_kinase_non-rcpt_TYK2.
DR   InterPro; IPR016045; Tyr_kinase_non-rcpt_TYK2_N.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF46; Non_rcpt_TYK2; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR00109; TYRKINASE.
DR   PRINTS; PR01827; YKINASETYK2.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF47031; FERM_3-hlx; 1.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS00660; FERM_1; FALSE_NEG.
DR   PROSITE; PS00661; FERM_2; FALSE_NEG.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat; SH2 domain;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1   1187       Non-receptor tyrosine-protein kinase
FT                                TYK2.
FT                                /FTId=PRO_0000088177.
FT   DOMAIN       26    431       FERM.
FT   DOMAIN      450    529       SH2; atypical.
FT   DOMAIN      589    875       Protein kinase 1.
FT   DOMAIN      897   1176       Protein kinase 2.
FT   NP_BIND     903    911       ATP (By similarity).
FT   ACT_SITE   1023   1023       Proton acceptor (By similarity).
FT   BINDING     930    930       ATP (By similarity).
FT   MOD_RES     292    292       Phosphotyrosine.
FT   MOD_RES     499    499       Phosphoserine.
FT   MOD_RES     604    604       Phosphotyrosine (By similarity).
FT   MOD_RES     884    884       Phosphoserine.
FT   MOD_RES    1054   1054       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   VARIANT       4      4       R -> C (in dbSNP:rs35163004).
FT                                /FTId=VAR_037796.
FT   VARIANT       4      4       R -> H (in dbSNP:rs12720343).
FT                                /FTId=VAR_020597.
FT   VARIANT      81     81       A -> V (in dbSNP:rs1049619).
FT                                /FTId=VAR_037797.
FT   VARIANT     197    197       R -> H (in dbSNP:rs12720263).
FT                                /FTId=VAR_020598.
FT   VARIANT     362    362       V -> F (in dbSNP:rs2304256).
FT                                /FTId=VAR_020599.
FT   VARIANT     363    363       G -> S (in dbSNP:rs2304255).
FT                                /FTId=VAR_020600.
FT   VARIANT     386    386       V -> M (in dbSNP:rs55956017).
FT                                /FTId=VAR_041870.
FT   VARIANT     442    442       R -> Q (in dbSNP:rs2304254).
FT                                /FTId=VAR_037798.
FT   VARIANT     684    684       I -> S (in dbSNP:rs12720356).
FT                                /FTId=VAR_020286.
FT   VARIANT     703    703       R -> W (in dbSNP:rs55882956).
FT                                /FTId=VAR_041871.
FT   VARIANT     732    732       H -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041872.
FT   VARIANT     820    820       P -> H (in dbSNP:rs34046749).
FT                                /FTId=VAR_037799.
FT   VARIANT     928    928       A -> V (in dbSNP:rs35018800).
FT                                /FTId=VAR_041873.
FT   VARIANT    1104   1104       P -> A (in dbSNP:rs34536443).
FT                                /FTId=VAR_041874.
FT   VARIANT    1163   1163       E -> G (in dbSNP:rs55886939).
FT                                /FTId=VAR_041875.
FT   CONFLICT    869    869       L -> V (in Ref. 1; CAA38449).
FT   CONFLICT    882    882       P -> R (in Ref. 1; CAA38449).
FT   CONFLICT    887    888       SD -> VG (in Ref. 1; CAA38449).
FT   CONFLICT    891    891       V -> T (in Ref. 1; CAA38449).
FT   CONFLICT   1016   1016       A -> S (in Ref. 3; AAH14243).
FT   CONFLICT   1017   1018       QH -> HD (in Ref. 1; CAA38449).
SQ   SEQUENCE   1187 AA;  133650 MW;  F76C25D6A919EDBC CRC64;
     MPLRHWGMAR GSKPVGDGAQ PMAAMGGLKV LLHWAGPGGG EPWVTFSESS LTAEEVCIHI
     AHKVGITPPC FNLFALFDAQ AQVWLPPNHI LEIPRDASLM LYFRIRFYFR NWHGMNPREP
     AVYRCGPPGT EASSDQTAQG MQLLDPASFE YLFEQGKHEF VNDVASLWEL STEEEIHHFK
     NESLGMAFLH LCHLALRHGI PLEEVAKKTS FKDCIPRSFR RHIRQHSALT RLRLRNVFRR
     FLRDFQPGRL SQQMVMVKYL ATLERLAPRF GTERVPVCHL RLLAQAEGEP CYIRDSGVAP
     TDPGPESAAG PPTHEVLVTG TGGIQWWPVE EEVNKEEGSS GSSGRNPQAS LFGKKAKAHK
     AVGQPADRPR EPLWAYFCDF RDITHVVLKE HCVSIHRQDN KCLELSLPSR AAALSFVSLV
     DGYFRLTADS SHYLCHEVAP PRLVMSIRDG IHGPLLEPFV QAKLRPEDGL YLIHWSTSHP
     YRLILTVAQR SQAPDGMQSL RLRKFPIEQQ DGAFVLEGWG RSFPSVRELG AALQGCLLRA
     GDDCFSLRRC CLPQPGETSN LIIMRGARAS PRTLNLSQLS FHRVDQKEIT QLSHLGQGTR
     TNVYEGRLRV EGSGDPEEGK MDDEDPLVPG RDRGQELRVV LKVLDPSHHD IALAFYETAS
     LMSQVSHTHL AFVHGVCVRG PENIMVTEYV EHGPLDVWLR RERGHVPMAW KMVVAQQLAS
     ALSYLENKNL VHGNVCGRNI LLARLGLAEG TSPFIKLSDP GVGLGALSRE ERVERIPWLA
     PECLPGGANS LSTAMDKWGF GATLLEICFD GEAPLQSRSP SEKEHFYQRQ HRLPEPSCPQ
     LATLTSQCLT YEPTQRPSFR TILRDLTRLQ PHNLADVLTV NPDSPASDPT VFHKRYLKKI
     RDLGEGHFGK VSLYCYDPTN DGTGEMVAVK ALKADCGPQH RSGWKQEIDI LRTLYHEHII
     KYKGCCEDQG EKSLQLVMEY VPLGSLRDYL PRHSIGLAQL LLFAQQICEG MAYLHAQHYI
     HRDLAARNVL LDNDRLVKIG DFGLAKAVPE GHEYYRVRED GDSPVFWYAP ECLKEYKFYY
     ASDVWSFGVT LYELLTHCDS SQSPPTKFLE LIGIAQGQMT VLRLTELLER GERLPRPDKC
     PCEVYHLMKN CWETEASFRP TFENLIPILK TVHEKYQGQA PSVFSVC
//
